SCHEMBL10168175

SCHEMBL10168175

CS(=O)(=O)C(F)(F)C(=O)OC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.41
CYP17A1 P05093 3/20 0.41
CA2 P00918 2/20 0.38
NAAA Q02083 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
TSHR P16473 1/20 0.35
SCN9A Q15858 2/20 0.33
EPHX2 P34913 2/20 0.31
LMNA P02545 1/20 0.31
GABBR2 O75899 1/20 0.31
GABBR1 Q9UBS5 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
CA12 O43570 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686582 0.86 CYP19A1 (0.40) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL17068034 0.84 CYP19A1 (0.39) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL19042425 0.83 CA2 (0.41) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL17522547 0.82 CYP19A1 (0.37) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL17525074 0.82 CYP19A1 (0.37) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL686205 0.79 CYP19A1 (0.48) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL9764361 0.78 CYP19A1 (0.43) CYP19A1CYP17A1CA2NAAANPSR1
SCHEMBL14294660 0.77 ALDH1A1 (0.35) CYP19A1CYP17A1CA2SCN9AALDH1A1
SCHEMBL21392229 0.76 CYP19A1 (0.34) CYP19A1CYP17A1CA2NPSR1TSHR
SCHEMBL14703972 0.76 CYP17A1 (0.37) CYP19A1CYP17A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230341772-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN JSR CORPORATION (JP) 2023-10-26 US disclosed
US-20230161249-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-05-25 US disclosed
US-20120028196-A1 METHOD OF FORMING PATTERN AND ORGANIC PROCESSING LIQUID FOR USE IN THE METHOD FUJIFILM CORPORATION (JP) 2012-02-02 US disclosed
US-20120028196-A1 METHOD OF FORMING PATTERN AND ORGANIC PROCESSING LIQUID FOR USE IN THE METHOD FUJIFILM CORPORATION (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230341772-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN RER1, XRCC5, F12 CYP19A1 2673/4885CYP17A1 2352/4885CA2 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.